Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway

Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to 4 weeks of treatment. The objective of this study was to analyze changes within...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Zhu, Hongjie, Bogdanov, Mikhail B., Boyle, Stephen H., Matson, Wayne, Sharma, Swati, Matson, Samantha, Churchill, Erik, Fiehn, Oliver, Rush, John A., Krishnan, Ranga R., Pickering, Eve, Delnomdedieu, Marielle, Kaddurah-Daouk, Rima, Network, Pharmacometabolomics Research
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2013
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3714282/
https://ncbi.nlm.nih.gov/pubmed/23874572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0068283
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg